This report marks the midway point of the 1/4/6×24 Campaign, which calls for the universal implementation of the best available TB regimens — as little as one month or once weekly for TB prevention, four months for drug-susceptible TB, and six months for drug-resistant TB — by the end of 2024. The report takes stock of what 1/4/6×24 has accomplished so far since its founding in 2022, and analyzes remaining gaps to be filled to reach its ambitious goal by the end of this year — particularly pertaining to the “4” regimen, for which uptake has been sorely limited and which original modeling shows has the potential to reduce total treatment time by 6.3 million years through 2030. Read the report here.
top of page
Recent Posts
See AllPhumeza Tisile was treated for MDR-TB in 2010 and suffered severe side effects from the drug, kanamycin. Her experiences drove her to...
110
The WHO has released new guidelines for prophylactic TB treatments. Among the updates to the guidelines are adjusted dosage...
90
The TB-CAPT consortium released a new study recently that showed that the new Xpert MTB/XDR testing can provide signigificantly faster...
140
bottom of page
Comentarios